We investigated the clinical characteristics of elderly sclerotic patients showing a high level of ASI (arterial stiffness index) in comparison with patients showing a lower level. Sclerotic outpatients (n = 390, 111 males, 279 females, mean age: 78.1±7.8) complicated by hypertension, diabetes mellitus, cerebral infarction, hyperlipidemia and ischemic heart disease were followed for about 4 years. The ASI was measured non-invasively by computerized oscillometry using CardioVision MS-2000.
A relationship between ASI and age was observed (r = 0.31, p < 0.001) in elderly sclerotic patients. The rate of patients was 29.7% for an ASI less than 70, 36.7% for ASI: 71-140, 17.4% for ASI: 141-210, 7.9% for ASI: 211-280, 4.9% for ASI: 281-350 and 3.3% for ASI more than 351. The death rates among elderly outpatients were compared by ASI level. The rate was 0.0952 (dead/alive: 6/63) for patients showing an ASI more than 211 and was 0.0336 (11/327) for patients showing an ASI less than 210, which was not significantly different by chi-square test. The rate was further calculated by Mantel-Haenszel test stratified by age and sex, showing no significance between two groups. Age and sex were not confounding factors. Similarly, the rate was 0.1250 (4/32) for those with an ASI more than 281, while it was 0.0258 (3/116) for patients showing an ASI less than 70, and the difference was not significant. The Mantel-Haenszel test also did not show a significant difference between those groups. There was no relation between ASI level and the death rate among patients. Finally, we compared disease and laboratory data between the two groups with an ASI showing more than 211 or less than 70. The rate of DM and CKD were significantly higher among patients with an ASI more than 211 group. In patients with an ASI more than 211, values for BUN, Cr, HbA1C, mIMT and Plt Aggre were significantly higher (p < 0.001) than those in patients with an ASI less than 70, while differences in TP, Alb, Cr, CRP, TC and TG were not significant.
It could be concluded that although ASI was not associated with the death rate, it was a thrombogenic predictor even among elderly outpatients.
View full abstract